OnCo
trialsTrial

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer

A phase 3 trial of Ibandronic acid and Zoledronic acid in Breast cancer and Metastatic cancer, run by Wales Cancer Trials Unit, with a status the registry has not verified recently.